+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 0 - 48Hours
All Genders
ID02140255

Early Intensive Antiretroviral Therapy in Infants With HIV to Explore Remission Outcomes

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-09-09

1120

Participants Needed

47

Research Sites

204 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of early intensive antiretroviral therapy ART with or without broadly neutralizing antibodies on achieving HIV remission in infants living with HIV. This phase III study includes two groups infants born to mothers with limited or no antiretroviral use during pregnancy and infants diagnosed with HIV within 48 hours of birth who start ART immediately. The goal is to see if early treatment can suppress HIV to undetectable levels. Participants will receive one of seven intensive ART regimens combining nucleoside reverse transcriptase inhibitors NRTIs with drugs like nevirapine, lopinavirritonavir, raltegravir, dolutegravir, and monoclonal antibodies VRC01 or VRC07-523LS. Therapy begins within 48 hours of birth and may include switches in medication based on age and weight. The study has four steps initial evaluation and therapy start, up to 192 weeks of treatment with monitoring, possible treatment interruption for those with sustained viral suppression, and re-initiation of ART if viral rebound occurs. During the study, infants undergo regular HIV testing, safety monitoring, and immune assessments. Researchers track how many achieve HIV remission by week 48 and monitor viral suppression and adverse events through week 192. If treatment interruption is attempted, participants are closely observed for viral rebound for up to ten years, followed by monitoring after ART re-initiation until age five or six months after viral suppression. The entire study may last several years to evaluate long-term outcomes.

CONDITIONS

Brief Title

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

Research Team

A

Anne Coletti, MS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here